FBDD(フラグメントベースの創薬)の世界市場

【英語タイトル】Fragment-based Drug Discovery Market (Service Component: Fragment screening and Fragment Optimization; End-user: Biopharmaceutical Companies, CROs and, Academic and Research Institutions) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Transparency Market Researchが出版した調査資料(TMR602379)・商品コード:TMR602379
・発行会社(調査会社):Transparency Market Research
・発行日:2015年10月
・ページ数:111
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,795 ⇒換算¥541,835見積依頼/購入/質問フォーム
Multi UserUSD7,795 ⇒換算¥880,835見積依頼/購入/質問フォーム
Corporate LicenseUSD10,795 ⇒換算¥1,219,835見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、FBDD(フラグメントベースの創薬)の世界市場について調査・分析し、FBDD(フラグメントベースの創薬)の世界市場概要、市場動向、市場規模、主要地域別分析、関連企業情報などをお届けいたします。
【レポートの概要】

The increasing search for new drugs to treat complicated medical problems has led to a surge in the global fragment-based drug discovery market. Furthermore, the growth of the global fragment-based drug discovery market has also led to dominance of biopharmaceutical companies, as the market requires a system for identification of lead compounds in the process of drug discovery.

The report published by Transparency Market Research on the global fragment-based drug discovery market gives a comprehensive overview of the important dynamics and trends. The report assesses the threat from new entrants, threat of substitute products or services, bargaining power of customers, bargaining power of suppliers, and the intensity of competitive rivalry with the help of a Porter’s five forces analysis. Furthermore, it also evaluates the strengths, weaknesses, opportunities, and threats of the market with the help of a SWOT analysis. The report gives a clear understanding of the competitive landscape and segmentation of the market and an overview of the global fragment-based drug discovery market to enable its readers to make well-informed business decisions.

Overview of Global Fragment-Based Drug Discovery Market

The drivers for the global fragment-based drug discovery market are its time-saving attributes and quick access to biophysical fragment screening techniques. Fragment-based drug discovery has become a method of designing unique molecules. This technique uses smaller ‘fragments or ligands’, which have lower molecular weights. The main restraint on the global fragment-based drug discovery market is the weak potency of a few compounds that are derived from fragment screening. The other conspicuous restraint on this market is the need for special ‘fragment libraries’ for conducting research.

The global fragment-based drug discovery market has been segmented into fragment screening and fragment optimization. The fragment screening segment is further sub-segmented into biophysical techniques and non-biophysical techniques. Biophysical techniques include isothermal titration calorimetry (ITC), nuclear magnetic resonance (NMR) spectroscopy, fluorescence polarization (FP), differential scanning fluorimetry (DSF), surface plasmon resonance, X-ray crystallography, assay (thermal shift), biolayer interferometry, capillary electrophoresis, mass spectrometry, and others (biochemical assays). The end-use applications encouraging the growth of this market are CROs, biopharmaceutical companies, and academic and research institutions. Geographically, the global fragment-based drug discovery market is divided into regions such as North America, Asia Pacific, Europe, Latin America, and Rest of the World.

North America dominated the global fragment-based drug discovery market due to growing awareness about this sector and the high level of its adoption by pharmaceutical companies. However, in the coming years, the Asia Pacific fragment-based drug discovery market will witness phenomenal growth due to the growing number of research and development activities.

Companies Mentioned in the Global Fragment-Based Drug Discovery Market Report

The important players in the global fragment-based drug discovery market are Astex Pharmaceuticals, Beactica AB, Structure Based Design, Inc., Alveus Pharmaceuticals Pvt. Ltd., Emerald BioStructures, Inc., Evotec AG, Crown Bioscience, Inc., Kinetic Discovery Limited, Sprint Bioscience, Proteros Fragments GmbH, Charles River Laboratories International, Inc., and Sygnature Discovery.

【レポートの目次】

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 Research Methodology: Assumptions
Chapter 2 Executive Summary
2.1 Global Fragment-based Drug Discovery Market, Estimates and Forecast, By Revenue, 2013–2023 (US$ Mn)
2.2 Global Fragment-based Drug Discovery Market Revenue, by Services, 2014 (US$ Mn)
2.3 Global Fragment-based Drug Discovery Market Revenue, by End-user, 2014 (US$ Mn)
2.4 Global Market Share, by Geography, 2014 and 2023 (Value %)
2.5 Fragment-based Drug Discovery Market Snapshot
Chapter 3 Fragment-based Drug Discovery Market Overview
3.1 Introduction
3.1.1 Hit to Lead
3.1.2 Progression to Candidates from Fragment Leads
3.2 Event Impact Analysis
3.3 Future Trends and Developments
3.4 Market Drivers
3.4.1 Simpler and less time consuming technique
3.4.2 Streamlining and easy access to advanced biophysical techniques
3.5 Restraints
3.5.1 Lower level of potency in few of the compounds derived from fragment screening
3.5.2 Requirement of high protein and unique fragment library for conducting studies
3.6 Opportunities
3.6.1 Merging of computational biology with biophysical techniques
3.6.2 Emerging economies to offer sustained growth opportunities
3.7 Porter’s Five Forces Analysis
3.8 Recent Developments in Fragment-based Drug Discovery
3.9 Fragment-based Drug Discovery: Case Histories
3.10 Market Share – Fragment-based Drug Discovery Market (2014) (%)
3.11 Market Attractiveness Analysis – Fragment-based Drug Discovery Market
Chapter 4 Market Segmentation – By Services Component
4.1 Introduction
4.2 Comparative Analysis of FBDD and HTS
4.3 Global Fragment Screening Market Revenue for FBDD, 2013 – 2023 (US$ Mn)
4.3.1 Global Biophysical Techniques Market for FBDD (US$ Mn), 2013 – 2023)
4.3.1.1 Global NMR Spectroscopy Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.2 Global DSF Assay Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.3 Global Fluorescence Polarization (FP) Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.4 Global Isothermal Titration Calorimetry (ITC) Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.5 Global X-ray Crystallography Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.6 Global SPR Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.7 Global Biolayer Interferometry Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.8 Global Mass Spectrometry (MS) Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.9 Global Capillary Electrophoresis (CE) Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.1.10 Global Other (Biochemical Assays) Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.3.2 Global Non-biophysical Techniques Market Revenue for FBDD, 2013–2023 (US$ Mn)
4.4 Global Fragment Optimization Market Revenue for FBDD, 2013–2023 (US$ Mn)
Chapter 5 Market Segmentation – By End-user
5.1 Introduction
5.2 Global Market for Fragment-based Drug Discovery in Biopharmaceutical Companies, 2013–2023 (US$ Mn)
5.3 Global Market for Fragment-based Drug Discovery in CROs, 2013–2023 (US$ Mn)
5.4 Global Market for Fragment-based Drug Discovery in Academic and Research Institutions, 2013–2023 (US$ Mn)
Chapter 6 Fragment-based Drug Discovery Market – Regional Analysis
6.1 Global Overview
6.2 North America Fragment-based Drug Discovery Market Overview
6.2.1 U.S. Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.2.2 Canada Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.3 Europe Fragment-based Drug Discovery Market Overview
6.3.1 Germany Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.3.2 U.K. Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.3.3 Rest of Europe Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn)
6.4 Asia Pacific Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn)
6.4.1 Japan Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.4.2 Australia Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.4.3 Rest of Asia Pacific Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn)
6.5 LATAM Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn)
6.5.1 Brazil Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.5.2 Rest of LATAM Fragment-based Drug Discovery Market Revenue, 2013 – 2023, (US$ Mn)
6.6 RoW Fragment-based Drug Discovery Market Revenue, 2013–2023 (US$ Mn)
Chapter 7 Company Profiles
7.1 Astex Pharmaceuticals
7.2 Alveus Pharmaceuticals Pvt. Ltd.
7.3 Beactica AB
7.4 Charles River Laboratories International, Inc.
7.5 Crown Bioscience, Inc.
7.6 Emerald BioStructures, Inc.
7.7 Evotec AG
7.8 Kinetic Discovery Limited
7.9 Proteros Fragments GmbH
7.10 Sprint Bioscience
7.11 Structure Based Design, Inc.
7.12 Sygnature Discovery



★調査レポート[FBDD(フラグメントベースの創薬)の世界市場] (コード:TMR602379)販売に関する免責事項を必ずご確認ください。
★調査レポート[FBDD(フラグメントベースの創薬)の世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆